Nordenskjöld, A., Fohlin, H., Fornander, T., Löfdahl, B., Skoog, L., & Stål, O. (2016). Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer. Breast Cancer Res Treat.
Chicago Stili AlıntıNordenskjöld, Anna, Helena Fohlin, Tommy Fornander, Britta Löfdahl, Lambert Skoog, ve Olle Stål. "Progesterone Receptor Positivity Is a Predictor of Long-term Benefit From Adjuvant Tamoxifen Treatment of Estrogen Receptor Positive Breast Cancer." Breast Cancer Res Treat 2016.
MLA AlıntıNordenskjöld, Anna, et al. "Progesterone Receptor Positivity Is a Predictor of Long-term Benefit From Adjuvant Tamoxifen Treatment of Estrogen Receptor Positive Breast Cancer." Breast Cancer Res Treat 2016.